Meihua International Medical Technologies First Half 2023 Earnings: EPS: US$0.29 (vs US$0.29 in 1H 2022)
Meihua International Medical Technologies (NASDAQ:MHUA) First Half 2023 Results
Key Financial Results
Revenue: US$48.2m (down 12% from 1H 2022).
Net income: US$7.06m (up 7.7% from 1H 2022).
Profit margin: 15% (up from 12% in 1H 2022). The increase in margin was driven by lower expenses.
EPS: US$0.29 (up from US$0.29 in 1H 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Meihua International Medical Technologies shares are down 19% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 4 warning signs for Meihua International Medical Technologies (2 shouldn't be ignored!) that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
